Bruker Corp (BRKR) · Oct 29, 2026 · Other events
$3.9844 preferred dividend — $3.9844 per preferred share, payable December 1, 2026
Bruker’s dividend filing confirms the scheduled $3.9844 preferred-stock payout. It changes neither the company’s strategy nor its operating outlook.
Bruker is in the middle of a post-genomic life-science push spanning proteomics, spatial biology, diagnostics, and laboratory automation, while working to restore organic growth and expand margins. Its latest reported outlook already called for FY2026 revenue of $3.54–$3.57 billion and non-GAAP EPS of $2.10–$2.15, so this filing does not alter the operating story.
This is a scheduled preferred-stock obligation, not a new capital-allocation signal. The board declared the Series A mandatory convertible preferred dividend at $3.9844 per share, payable December 1, 2026, to holders of record November 15, 2026. The amount matches the quarterly rate established when the preferred stock was issued and the same amount declared earlier in 2026, making this confirmation rather than a surprise.
The filing barely touches the core business. It neither changes common-stock dividends nor updates guidance, financing plans, acquisitions, or the company’s growth-and-margin transition. The only incremental information is the next payment date and record date.
Bottom line: This is routine housekeeping for Bruker’s mandatory convertible preferred stock. It carries no new information about the company’s operating progress or strategy.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!